- Report
- February 2021
- 420 Pages
United States
From €2305EUR$2,400USD£1,985GBP
Parnate (tranylcypromine) is a monoamine oxidase inhibitor (MAOI) used to treat mental disorders such as depression, anxiety, and panic disorder. It is a prescription drug that works by increasing the levels of certain neurotransmitters in the brain, which can help improve mood and reduce symptoms of mental illness. Parnate is generally used as a last resort when other treatments have failed, as it can have serious side effects. It is usually taken in combination with other medications, such as antidepressants or antipsychotics.
Parnate is available in both generic and brand-name forms. It is typically taken orally, although it can also be administered as an injection. The drug is available in both immediate-release and extended-release forms.
The Parnate market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. Other companies include Sun Pharmaceuticals, Teva Pharmaceuticals, and Mylan. Show Less Read more